Nūhou ʻOihana
Hāʻawi ka lāʻau lapaʻau CD19/BCMA CAR-T pālua a BIOOCUS Medical Group i nā hopena hoʻohiki i ka Myasthenia Gravis Refractory: He huakaʻi a kahi maʻi ʻōpio
Ka Holomua Hoʻonaʻauao | Ua Paʻi ka Hui Lapaʻau ʻo Lu Daopei i kahi Haʻawina Lapaʻau Hou ma ka British Journal of Haematology
Ua paʻi ka Hui Lapaʻau ʻo Lu Daopei, i alakaʻi ʻia e Kauka Cao Xingyu lāua ʻo Polopeka Lu Peihua, i kahi pepa noiʻi lapaʻau koʻikoʻi ma ka Ka Nūpepa Pelekane o ka Hematology (Impact Factor 5.1). Ke noiʻi nei ke aʻo ʻana i ka palekana a me ka pono o ka hoʻoili ʻana o nā cell stem hematopoietic allogeneic (allo-HSCT) ma hope o ka lāʻau lapaʻau autologous CD7 CAR-T no ka leukemia lymphoblastic acute T-cell refractory a me ka relapsed (R/R T-ALL/T-LBL).
Hōʻike ka Haʻawina Multi-Center i ka Prognosis Maikaʻi no nā Maʻi Hematoma Malignancy e Hana ʻia ana e ka MMUD Allogeneic Stem Cell Transplant me ATG
Ua hōʻike ʻia kahi noiʻi nui ma waena o nā kikowaena ma Kina i nā hopena maikaʻi no nā poʻe maʻi me nā maʻi hematologic e hana nei i nā hoʻoili cell stem mismatched related donor (MMUD) me ATG no ka pale ʻana i ka GVHD.
Ka Moʻolelo o ka Mea Maʻi: B-ALL Kiʻekiʻe-Pilikia, Hoʻoili ʻana o ka Iwi ʻŌpū i 9 Mahina, ʻElua Makahiki Mahope Mai—He Hoʻomaka Olakino no kahi Koa ʻŌpio
Ua hana ʻia kahi hoʻoili iwi iwi kūleʻa i kahi keiki 9 mahina, i ʻike ʻia he Acute B Lymphoblastic Leukemia (B-ALL). ʻElua mau makahiki ma hope mai, ua ulu maikaʻi ke keiki a ua mākaukau no ke kula kamaliʻi.
Ke Hoʻomaopopo nei i ka Thalassemia: He Alakaʻi Piha i nā ʻAno Alpha a me Beta
ʻOi aku ma mua o hoʻokahi maʻi ka Thalassemia. Ke nānā nei kēia alakaʻi i ka alpha a me ka beta thalassemia, ko lākou mau kumu, nā hōʻailona, a me nā koho lapaʻau hou loa i loaʻa ma BIOOCUS International Medical Center.
Hōʻike ʻo Kauka Lu Peihua i ka holomua ma ka CAR-T Therapy ma ka 29th APBMT Annual Meeting
Ma ka Hālāwai Makahiki 29 o ka Hoʻoili Koko a me ka ʻAoʻao o ka ʻĀina ʻĀsia-Pasifika (APBMT), ua hāʻawi ʻo Kauka Lu Peihua i kahi haʻiʻōlelo koʻikoʻi e pili ana i ka holomua o ka lāʻau lapaʻau CAR-T ma Kina. Ua loaʻa i ka ʻikepili maoli o kāna hui mai ka hana lapaʻau ka mahalo honua, e hōʻike ana i kā lākou hāʻawi ʻana i ka mālama ʻana i nā maʻi koko.
ASH 2024: Hōʻike ka Hui Lu Daopei i 13 mau holomua noiʻi ma Hematology
Ma ka ʻaha kūkā ASH 2024 e hiki mai ana, e hōʻike ana ka hui lapaʻau o ka Halemai ʻo Lu Daopei i 13 mau ʻike noiʻi hou, e hōʻike ana i nā holomua i ka hematology a me ka hiki o ka lāʻau lapaʻau CAR-T, e hōʻoia hou ana i kā lākou kūpaʻa i ka hoʻomaikaʻi ʻana i nā hopena o ka mea maʻi.
Ke lanakila nei i ka Lymphoma me ka Dual CAR-T Therapy
Ma hope o ke kaua ʻana me ka lymphoma no ʻekolu mau makahiki, ua loaʻa i kahi wahine 61 makahiki ke kala piha ʻana ma o ka lāʻau lapaʻau CAR-T pālua hou ma BIOOCUS, e hōʻike ana i ka hiki ke hoʻololi i ke ola o nā lāʻau lapaʻau maʻi kanesa holomua.
Ke komo nei ʻo Bioocus i ka IGC 2024 e ʻimi i nā hui hou a me nā ʻano hoʻohālike ʻoihana ma Immuno-Gene a me Cell Therapy
Hauʻoli ʻo Bioocus e hui pū me ka 8th Immuno-Gene and Cell Therapy Congress (IGC 2024)! Ke kakali nei mākou i ka hana pū ʻana me nā loea honua a me ka ʻimi ʻana i nā hiʻohiʻona ʻoihana hou e kūlike me nā ʻenehana gene a me nā cell therapy hou loa. E hui pū kākou, e hoʻokumu i ka wā e hiki mai ana o ka immunotherapy.
Ka Pono Kiʻekiʻe o ka CD7 CAR-T Therapy no nā Malignancies B-Cell: He Huakaʻi Hou i ka Lapaʻau ʻana i ka Maʻi Kanesa
Hōʻike ka noiʻi hou loa i ka pono a me ka palekana o ka lāʻau lapaʻau CD7 CAR-T cell i ka mālama ʻana i ka relapsed a refractory B-cell acute lymphoblastic leukemia (B-ALL) a me T-cell lymphoblastic lymphoma (T-LBL). Hana ʻia e BIOOCUS me ka laulima ʻana me ka Halemai ʻo Lu Daopei, hōʻike ka noiʻi i nā hopena hoʻohiki no nā maʻi, e hāʻawi ana i kahi koho ikaika i ka chemotherapy maʻamau.
Ka hopena lōʻihi o ka CD19 CAR T-Cell Therapy i ka mālama ʻana i ka Relapsed/Refractory Acute Lymphoblastic Leukemia
Hōʻike kahi haʻawina hou i ka holomua lōʻihi o ka lāʻau lapaʻau CD19 CAR T-cell i ka mālama ʻana i nā maʻi me ka relapsed/refractory acute lymphoblastic leukemia (ALL) ma hope o ka hoʻoili ʻana o nā cell stem hematopoietic allogeneic, e hāʻawi ana i ka manaʻolana hou i ka hematology.
Hoʻolaha ʻo Bioocus i ka palena i ka mālama ʻana i ka maʻi leukemia lymphoblastic acute pediatric
Aia ʻo Bioocus ma ke alo o ka hoʻomohala ʻana i nā lāʻau lapaʻau CAR-T hanauna hou. ʻO ka puke hou a Kauka Chunrong Tong a me kāna hui ma ka Halemai ʻo Lu Daopei e hōʻike ana i nā holomua koʻikoʻi a me nā pilikia i ka hoʻohana ʻana i nā lāʻau lapaʻau CD19 CAR-T hanauna ʻelua i nā maʻi pediatric, e hōʻike ana i ka hoʻokō ʻana o Bioocus i ka mālama ʻana i ka maʻi kanesa hou.